Letosteine is a mucolytic[1] patented (U.S. patent 6987120) by Piero del Soldato of Milan, Italy.[2] He filed his application in 2000.
Clinical data | |
---|---|
Trade names | Viscotiol |
Other names | 2-[2-(ethoxycarbonylmethylsulfanyl)ethyl]-1,3-thiazolidine-4-carboxylic acid |
Routes of administration | Oral (gastroresistant capsules) |
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
DrugBank |
|
ChemSpider |
|
UNII |
|
KEGG |
|
ChEBI |
|
ECHA InfoCard | 100.053.509 |
Chemical and physical data | |
Formula | C10H17NO4S2 |
Molar mass | 279.37 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(what is this?) (verify) |